February 28, 2018 / 7:17 PM / 10 months ago

FDA approves Sorrento's painkiller patch

Feb 28 (Reuters) - The U.S. Food And Drug Administration on Wednesday approved Sorrento Therapeutics Inc’s ZTlido, a stick-on patch to treat nerve pain due to shingles.

Sorrento, which acquired Ztlido when it bought a majority stake in privately-owned SCILEX Pharmaceuticals Inc in November 2016, said it plans to launch the drug later this year.

The FDA had previously rejected the treatment in 2016.

Reporting by Tamara Mathias in Bengaluru; Editing by Arun Koyyur

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below